Paltusotine Hydrochloride 20 mg, 30 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 20 mg, 30 mg

Reference Brands: Palsonify (USA)

Category: Immune Disorder

Paltusotine Hydrochloride is a Immune Disorder product available as Tablets in strengths 20 mg, 30 mg. It corresponds to the reference brand Palsonify (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Paltusotine hydrochloride, marketed under the brand name Palsonify, is an orally administered medication developed by Crinetics Pharmaceuticals for the treatment of acromegaly in adults. Acromegaly is a rare endocrine disorder caused by excessive secretion of growth hormone, most commonly due to a benign tumor of the pituitary gland. This hormonal imbalance leads to abnormal enlargement of bones, organs, and soft tissues, resulting in serious long-term health complications if left untreated.

Paltusotine hydrochloride acts as a selective somatostatin receptor type-2 agonist. By targeting this receptor, it helps suppress the excessive release of growth hormone and subsequently reduces insulin-like growth factor-1 levels in the body. Unlike traditional injectable therapies used in acromegaly management, paltusotine hydrochloride is administered orally, offering a more convenient treatment option for patients.

The medication is indicated for adults with acromegaly who have had an inadequate response to pituitary surgery or for whom surgical intervention is not a suitable option. Its oral formulation provides improved treatment flexibility and patient compliance while maintaining effective hormonal control. Paltusotine hydrochloride represents an important advancement in the management of acromegaly, addressing both therapeutic efficacy and patient quality of life.